<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-P35</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-P35</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Evaluation of hepatic flow changes in early stages after extended hepatectomy by contrast enhanced ultrasound</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Fard</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>n.fard@dkfz-heidelberg.de</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Rezaei</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Emmami</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Saffari</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Golriz</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Mehrabi</surname><given-names>A</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Schlemmer</surname><given-names>H-P</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Delorme</surname><given-names>S</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>German Cancer Research Center, Department of Surgery, Heidelberg University, Germany</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>P35</fpage><lpage>P35</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Fard et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Fard et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/P35"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title>Background</title><p>Extended hepatectomy (EH) is the only curative procedure in patients with large or multi-nodular liver tumours. However, the alterations of the hepatic inflow (HF) after EH and the consequent complications like &#x0201c;small for size syndrome&#x0201d; (SFSS) are still challenging issues. Contrast-enhanced ultrasound (CEUS) is a non-invasive approach to evaluate liver haemodynamics with the advantages of imaging very low blood flow rates at the tissue perfusion level. The aim of this study is to detect the haemodynamic alterations after EH in early stage by CEUS in an experimental setting.</p></sec><sec sec-type="methods"><title>Method</title><p>An in vivo procaine model was studied using a low mechanical index in conjunction with single-level dynamic CEUS. A sulfur hexafluoride contrast agent (SonoVue; Bracco SpA, Milan, Italy) was applied in 5 pigs by intravenous bolus injection. Data were acquired before and after up to 75% sequential liver resections. Corresponding parameters of the time-intensity curve were measured using wash-in/wash-out curve software (Vuebox; Bracco SpA, Milan, Italy).</p></sec><sec><title>Result</title><p>Following sequential liver resection, the total HF increased gradually. In detail, the hepatic artery flow decreased 17% and portal vein flow increased around 70% after extended liver resection (75%). Also, with sequential liver resection, the PVP increased gradually up to 33% after extended liver resection (75%).</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Quantitative and qualitative measurement of THF alteration in early stages is feasible by CEUS. CEUS is a suitable modality for follow-up control after EH in order to prevent postoperative complications such as SFSS, which lead to liver failure.</p></sec></body></article>
